AJCN EB Program 2010 Early Registration
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hogervorst, J. G
Right arrow Articles by van den Brandt, P. A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hogervorst, J. G
Right arrow Articles by van den Brandt, P. A
Agricola
Right arrow Articles by Hogervorst, J. G
Right arrow Articles by van den Brandt, P. A
American Journal of Clinical Nutrition, Vol. 87, No. 5, 1428-1438, May 2008
© 2008 American Society for Nutrition


ORIGINAL RESEARCH COMMUNICATION

Dietary acrylamide intake and the risk of renal cell, bladder, and prostate cancer1,2,3

Janneke G Hogervorst, Leo J Schouten, Erik J Konings, R Alexandra Goldbohm and Piet A van den Brandt

1 From the Department of Epidemiology, School for Oncology and Developmental Biology (GROW), Maastricht University, Maastricht, Netherlands (JGH, LJS, and PAvdB); the Department Research and Development, Southern Region, Food and Consumer Product Safety Authority, Eindhoven, Netherlands (EJK); and the Department of Prevention and Health, TNO Quality of Life, Leiden, Netherlands (RAG)

Background: Acrylamide, a probable human carcinogen, was recently detected in various heat-treated carbohydrate-rich foods. Epidemiologic studies on the relation with cancer have been few and largely negative.

Objective: We aimed to prospectively examine the association between dietary acrylamide intake and renal cell, bladder, and prostate cancers.

Design: The Netherlands Cohort Study on diet and cancer includes 120852 men and women aged 55–69 y. At baseline (1986), a random subcohort of 5000 participants was selected for a case-cohort analysis approach using Cox proportional hazards analysis. Acrylamide intake was assessed with a food-frequency questionnaire at baseline and was based on chemical analysis of all relevant Dutch foods.

Results: After 13.3 y of follow-up, 339, 1210, and 2246 cases of renal cell, bladder, and prostate cancer, respectively, were available for analysis. Compared with the lowest quintile of acrylamide intake (mean intake: 9.5 µg/d), multivariable-adjusted hazard rates for renal cell, bladder, and prostate cancer in the highest quintile (mean intake: 40.8 µg/d) were 1.59 (95% CI: 1.09, 2.30; P for trend = 0.04), 0.91 (95% CI: 0.73, 1.15; P for trend = 0.60), and 1.06 (95% CI: 0.87, 1.30; P for trend = 0.69), respectively. There was an inverse nonsignificant trend for advanced prostate cancer in never smokers.

Conclusions: We found some indications for a positive association between dietary acrylamide and renal cell cancer risk. There were no positive associations with bladder and prostate cancer risk.




This article has been cited by other articles:


Home page
Am J EpidemiolHome page
L. J. Schouten, J. G. F. Hogervorst, E. J. M. Konings, R. A. Goldbohm, and P. A. van den Brandt
Dietary Acrylamide Intake and the Risk of Head-Neck and Thyroid Cancers: Results From the Netherlands Cohort Study
Am. J. Epidemiol., October 1, 2009; 170(7): 873 - 884.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. C. Larsson, A. Akesson, and A. Wolk
Dietary Acrylamide Intake and Prostate Cancer Risk in a Prospective Cohort of Swedish Men
Cancer Epidemiol. Biomarkers Prev., June 1, 2009; 18(6): 1939 - 1941.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
J. G. F. Hogervorst, L. J. Schouten, E. J. M. Konings, R. A. Goldbohm, and P. A. van den Brandt
Lung Cancer Risk in Relation to Dietary Acrylamide Intake
J Natl Cancer Inst, May 6, 2009; 101(9): 651 - 662.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
L. A. Mucci and H.-O. Adami
The Plight of the Potato: Is Dietary Acrylamide a Risk Factor for Human Cancer?
J Natl Cancer Inst, May 6, 2009; 101(9): 618 - 621.
[Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. G.F. Hogervorst, L. J. Schouten, E. J.M. Konings, R. A. Goldbohm, and P. A. van den Brandt
Dietary Acrylamide Intake and Brain Cancer Risk
Cancer Epidemiol. Biomarkers Prev., May 1, 2009; 18(5): 1663 - 1666.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
O. Doroshyenko, U. Fuhr, D. Kunz, D. Frank, M. Kinzig, A. Jetter, Y. Reith, A. Lazar, D. Taubert, J. Kirchheiner, et al.
In vivo Role of Cytochrome P450 2E1 and Glutathione-S-Transferase Activity for Acrylamide Toxicokinetics in Humans
Cancer Epidemiol. Biomarkers Prev., February 1, 2009; 18(2): 433 - 443.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. G. F. Hogervorst, L. J. Schouten, E. J. M. Konings, R. A. Goldbohm, and P. A. van den Brandt
Dietary Acrylamide Intake Is Not Associated with Gastrointestinal Cancer Risk
J. Nutr., November 1, 2008; 138(11): 2229 - 2236.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by The American Society for Nutrition